çalışmalara ihtiyaç duyulmaktadır.
7. KAYNAKLAR
AHONEN, M.H., TENKANEN, L., TEPPO, L., HAKAMA, M., TUOHIMAA, P. 2000. Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland). Cancer Causes Control 11: 847-52.
ALLEN, T., LANDSDOWNE, G., PROVOST, S.C. 1998. Vitamin D3 enhances mood in healthy subjects during winter. Psychopharmacology 135:319-323.
ALVAREZ, L.B., TERAN, J, ALONSO, J.L., ALEGRE, J., ARROYO, I., VİEJO, J.L. 1992. Lack of association between fibromyalgia and sleep apnoea syndrome. Ann Rheum Dis 51, 108–11.
ASDA 1997. The International Classification of Sleep Disorders, Revised: Diagnostic and Coding Manual. American Sleep Disorders Association 52-8.
ASDA 1997. Diagnostic Classification Steering Committee. The International Classification of Sleep Disorders. Diagnostic and Coding Manual. 2nd edition. Lawrence, KS: Allen Press Inc. 29-31.
ANCH, A.M., LUE, F.A., MACLEAN, A.W., MOLDOFSKY, H. 1991. Sleep physiology and psychological aspects of the fibrositis (fibromyalgia) syndrome.
Can J Psychol 45: 179-84.
BARCELO, A., ESQUINAS, PIEROLA, J., DE LA PENA, M., SANCHEZDE-LA- TORRE, M., MONTSERRAT, J.M., MARİN, J., DURAN, M., ARQUE, J.M. BAUCA, F. 2012. Vitamin D status and parathyroid hormone levels in patients with obstructive sleep apnea. Respiration
BARIŞ, YL., ARTVİNLİ, M., et al: Somnolance and slepping disturbances due to intermittant upper airway obstruction in obese patient. Path. Resp. 1973 9: 630-35
BENGTSSON, A., BENGTSSON, M. 1988. Regional sympathetic blockade in primary fibromyalgia. Pain. 33:161−7.
BENGTSSON, A., HENRIKSSON, K.G., LARSSON, J. 1986. Reduced high energy phosphate levels in the painful muscles of patients with primary fibromyalgia.
BLOCK, S.R. 2004. Vitamin D, deficiency is not associated with nonspecific musculoskeletal pain syndromes including fibromyalgia. Mayo Clin Proc. 79:1585–91.
BOISSEVAN, M.D., MCCAIN, G.A. 1991. Toward an integrated understanding of fibromyalgia syndrome, I. Medical and pathophysiological aspects; Pain, 45, 227- 38.
BOZKURT, N.C., CAKAL, E., SAHİN, M., OZKAYA, E.C., FIRAT, H., DELİBAS, T. 2012. The relation of serum 25-hydroxyvitamin-D levels with severity of obstructive sleep apnea and glucose metabolism abnormalities. Endocrine 41:518e 25
BRADLEY, L.A., ALARCON, G.S. 1997. Fibromyalgia: Arthritis and Allied Conditions. Ed by Kopman WJ. 13th edition. Vol 1, Lea-Febiger, Philedelphia, pp:1619-39 BUSKILA, D., NEUMANN, L., HERSMAN, E., GEDALİA, A., Press, J., Sukenik, S.
1995. Fibromyalgia syndrome in children - outcome study. J Rheumatol. 22: 525–28
CARLANDER, B., PUECH-CATHALA, A.M., JAUSSENT, I. 2011. Low vitamin D in narcolepsy with cataplexy. Plos One 6: e20433.
COHEN, H., NEUMANN, L., SHORE, M. 2000. Autonomic dysfunction in patients with fibromyalgia: application of power spectral analysis of theart rate variability.
Semin Arthritis Rheum 29: 217-27.
CORDERO, M.D., ALCOCER-GÓMEZ, E., CANO-GARCÍA, F.J., DE MİGUEL, M., SÁNCHEZ-ALCÁZAR, J.A., MORENO FERNÁNDEZ, A.M. 2010. Low levels of serotonin in serum correlates with severity of fibromyalgia. Med Clin 135(14):644-6.
ÇAPACI, K., HEPGÜLER, S. 1998. Fibromiyalji Sendromu: Etiyopatogenez. Ege Fiziksel Tıp ve Rehabilitasyon Dergisi 4 (3): 219-225. edition. Ed Klippel JH, Dieppe PA, 2000: 15.1-12.
DANIEL, D., PIROTTA, M.V. 2011. Fibromyalgia should we be testing and treating for vitamin D deficiency? Aust Fam Physicia. 40: 712–6.
DE REZENDE, PC., GRILLO, LP., DAS CHAGAS MEDEIROS, MM. 2010. Evaluation of 25-hydroxivitamin D serum levels in patients with fibromyalgia. J Clin Rheumatol.;16:365–9.
EL MAGHRAOUI, A., TELLAL, S., ACHEMLAL, L., NOUIJAI, A., GHAZI, M., MOUNACH, A., BEZZA, A., DEROUICHe, M. 2006. Bone turnover and hormonal perturbations in patients with fibromyalgia. Clin Exp Rheumatol. 24(4):428-31.
ERDEN, E.Ş., YENGİL, E., TUNCEL, E., BİLGİÇ, H.K., DEMİRKÖSE, M., MOTOR, S., GENÇ, S. 2014. Investigation of the relationship between mean platelet volume and obstructive sleep apnea syndrome. J Clin Exp Invest 4(4):492-6. FRORIEP, R., 1843. Ein Beitrag zur Pathologie des Rheumatismus. Weimar
GOLDENBERG, D.L,. 2000. Fibromyalgia and related syndromes. Rheumatology second
edition. Ed Klippel J.H., Dieppe, P.A. 15.1-12.
GRANT, W.B., GARLAND, C.F. 2006. The association of solar ultraviolet B (UVB) with reducing risk of cancer: multifactorial ecologic analysis of geographic variation in age-adjusted cancer mortality rates. Anticancer Res 26: 2687–2699. GRIEP, E.N., BOERSMA, J.W., DE KLOET, E.R. 1994. Pituitary release of growth hormone and prolactin in the primary fibromyalgia syndrome. J Rheumatol 21(11): 2125–30.
GÜR, A., ÇEVİK, R., NAS, K., SARAÇ, A.J., ÖZEN, S. 2006. Quality of life in young fibromyalgia patients and effect of deppression Applar journal of Rheumatology. 9: 70–78
GÜREL, F.S., İNAN, G. 2001. Çocukluk çağı obezitesi tanı yöntemleri prevalansı ve etiyolojisi. ADÜ Tıp Fakültesi Dergisi 2(3):39-46
HARDING, S.M. 1998. Sleep in fibromiyalgia patients: subjective and objective findings.
Am J Med Sci 315: 367-76
HOLICK, M.F. 2003. Vitamin D: A Millenium Perspective, Journal of Cellular Biochemistry 88: 296-307
HOLICK, M.F. 2004. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancer and cardiovascular disease. Am J Clin Nutr 80(6): 1678-1688.
HOLICK, M.F. 2003. Vitamin D Deficiency: What a Pain It Is. Mayo Clin Proc 78: 1457-1459
HORST, R.L., HOLLIS, B.W. 1999. Vitamin D assays and their clinical utility. In: Holick MF, ed. Physiology, Molecular Biology, and Clinical Applications. Totowa, NJ: Humana Press Inc; 239-271.
İNANICI, F. 2005. Fibromiyalji ve Miyofasial Ağrı Sendromları. Türkiye Klinikleri
Fiziksel Tıp ve Rehabilitasyon Dergisi 10: 11-18.
JENNUM, P., DREWES, A.M., ANDREASEN, A., NİELSEN, K.D. 1993. Sleep and other symptoms in primary fibromiyalgia and in healty controls. J Rheumatol 20: 1756–1759
JENNUM, P., RIHA, R.L. 2009. Epidemiology of sleep apnoea/hypopnoea syndrome and sleep-disordered breathing. European Respiratory Journal. 33:907-914.
JOSEPH, E. 2004. The Measurement of vitamin D analytical aspects. Zerweck Annals of Clinical Biochemistry; pg.272
KOÇANOĞULLARI, H. 1999. Fibromyalji sendromu. Ed Gümüşdiş G, Doğanavşargil E, Klinik Romatoloji. Deniz matbaası, İstanbul 549-54.
KOO, W.W.K., TSANG, R.C. 2005. Calcium and Magnesium Homeostasis. In: MacDonald MH, Seshia MMK, Mullet MD, editors. Avery’s Neonatology
Pathophysiology &Management of the Newborn, 6th edition. Philadelphia: Lippincott W&W, p.847- 875.
KÖKTÜRK, O., TATLICIOĞLU, T., KEMALOĞLU, Y., FIRAT, H., ÇETİN, N. 1997. Habitüel horlaması olan olgularda obstrüktif sleep apne sendromu prevalansı.
Tüberküloz ve Toraks Dergisi. 45:7-11.
KÖKTÜRK, O., ULUKAVAK, T. 2002. Obstrüktif uyku apne sendromu ile ilişkili hastalıkları. Tüberküloz ve Toraks Dergisi 50: 104-118.
KÖKTÜRK, O. 2002. Obstrüktif uyku apne sendromu fizyopatolojisi. Uyku Bozuklukları Toraks Derneği Okulu Merkezi Kursları Ankara.
KÖKTÜRK, O. 2007. Uykuda Solunum Bozuklukları. Türk Toraks Derneği 6. Kış Okulu
Kitabı. İzmir. 85-100.
KÖKTÜRK, O. 2008. Uykuda solunum bozuklukları. Türk Toraks Derneği 6. Kış Okulu Kitabı, Ilıca-Çeşme, 2007 Med-Special Topics
LANDSDOWNE, A.T.G., PROVOST, S.C. 1998. Vitamin D3 enhances mood in healthy subjects during winter. Psychopharmacology 135: 319–323.
LEWIS, J.M., COLEY, J.L.B., FRONTRIER, T.H. 2011. Fibromyalgia syndrome and vitamin D. J Musculoskeletal Pain. 19: 164–6.
MARCUS, D.A., 2005. A Primary Care Guide to Practical Management. In Chronic Pain. pp 15-30. PA Human Pres. Pain Institute, University of Pittsburgh, Pittsburgh.
MAY, K.P., WEST, S.G., BAKER, M.R., EVERETT, D.W. 1993. Sleep apnea in male patients with the fibromyalgia syndrome. Am J Med 94 (5): 505-8.
MCCAIN, G.A., TİLBE, K.S. 1989. Diurnal hormone variation in fibromyalgia syndrome: a comparison with rheumatoid arthritis. J Rheumatol Suppl. 19: 154-7. MEASE, P. 2005. Fibromyalgia syndrome: Review of clinical presentation, pathogenesis,
outcome measures and treatment. The Journal of Rheumatology. 32: 6-21. METE, T., YALCIN, Y., BERKER, D., CİFTCİ, B., GUVEN, S.F., TOPALOGLU, O.
2013. Obstructive sleep apnea syndrome and its association with vitamin D deficiency. J Endocrinol Invest PMID: 23558409.
MOLDOFSKY, H., SCARİSBRİCK, P., ENGLAND, R., SMYTH, H. 1975. Musculoskeletal symptoms and non-REM sleep disturbance in patients with “fibrositis syndrome” and healthy subjects. Psychosom Med. 37(4):341-51. MOLONY, R.R., MACPEEK, D.M., SCHİFFMAN, P.L. 1986. Sleep, sleep
apnea and the fibromyalgia syndrome. J Rheumatol 13, 797–800.
NEECK, G. 2002. Patogenic mechanisms of fibromyalgia. Elsevier Ageing research Reviews 1;243–255
NORREGAARD, J., Bülov, P.M., Washergoard, P. 1995. Muscle strength, voluntary, activation and cross sectional muscle area in patients with fibromyalgia; British
Journal of Rheumatology 34,: 925-931.
OKIFUJI, A., DONALDSON, G.W., BARCK, L., FİNE, P.G. 2010. Relationship between fibromyalgia and obesity in pain, function, mood, and sleep. J
OLAMA, S.M., SENNA, M.K., ELARMAN, M.M., ELHAWARY, G. 2013. Serum vitamin D level and bone mineral density in premenopausal Egyptian women with fibromyalgia. Rheumatol Int 33:185-92.
ÖZLÜ, T., METİNTAŞ, M., KARADAĞ, M., KAYA, A. 2010. Solunum Sistemi ve Hastalıkları. Bölüm: Uykuda solunum bozuklukları. İstanbul 2097- 2247.
PLUMB, R., CASTRO-PEREZ, J., GRANGER, J. 2004, Maximizing chromatographic resolution of metabolites using ultra performance liquid chromatography (UPLC (TM)), LC GC NORTH AMERICA, Pages: 59-59, ISSN: 1527-5949
POULIOT, Z., PETERS, M., NEUFELD, H., KRYGER, M.H. 1997. Using self-reported questionnaire data to prioritize OSA patients for polysomnography. Sleep 20(3):232-6.
PRABHALA, A., GARG, R., DANDONA, P. 2000. Severe myopathy associated with vitamin D deficiency in western New York. Arch Intern Med. 160: 1199-203. RIZZI, M., SARZI-PUTTINI, P., ATZENI, F., CAPSONI, F., ANDREOLI, A., PECIS,
M. 2004. Cyclic Alternating Pattern: A new marker of sleep alternation in patients with fibromiyalgia? J rhematol 31: 1193-9
ROIZENBLATT, S., MOLDOFSKY, H., BENEDİTO-SİLVA, A.A. 2001. Alpha sleep characteristics in fibromyalgia. Arthritis Rheumatism 44: 222-30.
RUSSEL, M.D., LITTMAN B., 1994. Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthritis Rheum 37 (11):1593–1601 RUSSELL, I.J., LARSON, A.A. 2009. Neurophysiopathogenesis of fibromyalgia
syndrome: a unified hypothesis. Rheum Dis Clin North Am 35(2):421−35.
RUSSELL, I.J., MICHALEC, J.E., VIPRAIO, G.A. 1992. Platelet 3H- imipramine uptake receptor density and serum serotonin levels in patients with fibromyalgia/fibrositis syndrome. J Rheumatol 19: 104–109.
SHINCHUK, L.M., HOLICK, M.F. 2007. Vitamin D and rehabilitation: improving functional outcomes. Nutr Clin Pract 22:297304.
STRADLING, J.R. 1995. Obstructive Sleep Apnea: Definitions, epidemiyolgy and natural history. Thorax. 50:683-89.
SWARTZ, M.E. 2005. Ultra Performance Liquid Chromatography (UPLC): An Introduction. Separation Science Re-Defined LCGC Supplement: 11.
TANDETER, H., GRYNBAUM, M., ZUILI, I. 2009. Serum 25-OH vitamin D levels in patients with fibromyalgia. IMAJ. 11:339–42.
UYAR, M., AYDIN, Ö. 2007. Miyofasyal Ağrı Sendromu ve Diğer Muskuloskeletal Kökenli Ağrılar. İçinde: Ağrı. Ed: Erdine S, Nobel Tıp Kitabevleri, s:476-493. ÜNLÜ, E. 2006. Fibromiyalji: Bir Kronik Ağrı Sendromu. In. Harris D. E, Budd R. C,
GENOVESE M. C, Firestein G. S, Sargent J. S, Sledge Clement. B (Eds). Çeviri Ed: Arasıl T. Kelley Romatoloji. Güneş Kitabevi Ltd. Şti. Ankara Cilt 1, 36: 522- 536.
VIETH, R. 2006. What is the optimal vitamin D status for health? Prog Biophys Mol Biol 92: 26-32.
WARNER, A.E., ARNSPIGER, A.S. 2008. Diffuse musculoskeletal pain is not associated with low vitamin D levels or improved by treatment with vitamin D. J
Clin Rheumatol.14:12–6.
WOLFE, F., RUSSELL, I.J., VIPRAIO, G., ROSS, K., ANDERSON, J. 1997. Serotonin levels, pain threshold and fibromyalgia symptoms in the general population. J
Rheumatol 24:555−9.
WOLFE, F., SMYTHE, H.A., YUNUS, M.B. 1990. The American College of Rheumatology 1990 criteria for classification of fibromyalgia. Arthritis Rheum. 33: 160-172.
WOLFE, F., CLAUW, D.J., FITZCHARLES, M.A., GOLDENBERG, D.L., KATZ, R.S., MEASE, P., RUSSELL, A.S., RUSSELL, I.J., WİNFİELD, J.B., YUNUS, M.B. 2010. The Am College of Rheumatol preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken). 62: 600-10.
WORTSMAN, J., MATSUOKA, L.Y., CHEN, T.C., LU, Z., HOLİCK, M.F. 2000. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 72: 690 –3. YENER, M., AKKUŞ, S. 2006. Fibromiyaljili hastalarda serum25-hidroksi D vitamini ve
YUNUS, M.B., Ahles, T.A., Aldag, J.C. 1991. Relationship of clinical features with psychological status in primary fibromyalgia. Arthritis Rheum 34: 15-21.
YUNUS, M.B. 2000. A comprehensive medical evaluation of patients with fibromyalgia syndrome. Rheum Dis Clin North Am. 28: 201-217.
ZERWEKH, J.E. 2004. The Measurement of vitamin D: analytical aspects Annals of Clinical Biochemistry; Health & Medical Complete pg.272.
ZITTERMANN, A. 2006. Vitamin D and disease prevention with special reference to cardiovascular disease. Prog Biophys Mol Biol 92: 39-48